Literature DB >> 22507559

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary.

Paul S Jellinger, Donald A Smith, Adi E Mehta, Om Ganda, Yehuda Handelsman, Helena W Rodbard, Mark D Shepherd, John A Seibel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22507559     DOI： 10.4158/ep.18.2.269

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  28 in total

1.  The role of the total cholesterol level in the assessment of the severity of myocardial infarction.

Authors:  S Venkata Rao; Mahendra Gandhe; S Indira; P Srilakshmi; Kalyan Goswami
Journal:  J Clin Diagn Res       Date:  2013-04-02

2.  Closed-loop gastric electrical stimulation versus laparoscopic adjustable gastric band for the treatment of obesity: a randomized 12-month multicenter study.

Authors:  T Horbach; G Meyer; S Morales-Conde; I Alarcón; F Favretti; M Anselmino; G M Rovera; J Dargent; C Stroh; M Susewind; A J Torres
Journal:  Int J Obes (Lond)       Date:  2016-09-16       Impact factor: 5.095

3.  Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients.

Authors:  Sadanand R Shetty; Soumitra Kumar; R P Mathur; Kamal H Sharma; Ashok D Jaiswal
Journal:  Indian Heart J       Date:  2015-02-26

4.  Predictive value of combining the level of lipoprotein-associated phospholipase A2 and antithrombin III for acute coronary syndrome risk.

Authors:  Jinyang Lu; Dandan Niu; Di Zheng; Quan Zhang; Wenhua Li
Journal:  Biomed Rep       Date:  2018-10-19

5.  Neutrophil-to-lymphocyte ratio as a predictor for cardiovascular diseases: a cohort study in Tianjin, China.

Authors:  Yuxin Zhao; Shuaixiang Zhang; Yue Yi; Ting Qu; Si Gao; Yizhou Lin; Hong Zhu
Journal:  J Hum Hypertens       Date:  2022-07-20       Impact factor: 2.877

6.  Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry.

Authors:  Angela Lowenstern; Shuang Li; Salim S Virani; Ann Marie Navar; Zhuokai Li; Jennifer G Robinson; Veronique L Roger; Anne C Goldberg; Andrew Koren; Michael J Louie; Eric D Peterson; Tracy Y Wang
Journal:  Am Heart J       Date:  2020-04-30       Impact factor: 4.749

7.  Implanted Closed-Loop Gastric Electrical Stimulation (CLGES) System with Sensor-Based Feedback Safely Limits Weight Regain at 24 Months.

Authors:  S Morales-Conde; I Alarcón Del Agua; L Busetto; F Favretti; M Anselmino; G M Rovera; M Socas-Macias; A Barranco-Moreno; R Province-Azalde; A J Torres
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

8.  Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.

Authors:  Ana Margarida Medeiros; Ana Catarina Alves; Pedro Aguiar; Mafalda Bourbon
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

9.  Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study.

Authors:  Noppadol Kietsiriroje; Rattana Leelawattana
Journal:  BMC Res Notes       Date:  2015-07-07

10.  Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010.

Authors:  Eun Roh; Seung-Hyun Ko; Hyuk-Sang Kwon; Nan Hee Kim; Jae Hyeon Kim; Chul Sik Kim; Kee-Ho Song; Jong Chul Won; Dae Jung Kim; Sung Hee Choi; Soo Lim; Bong-Yun Cha
Journal:  Diabetes Metab J       Date:  2013-12-12       Impact factor: 5.376
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.